Dr. Christian Schetter hired as Chief Scientific Officer at Rentschler Biopharma

pharmafile | September 22, 2021 | Appointment | Research and Development  

Rentschler Biopharma has announced the appointment of Dr. Christian Schetter as their new CSO. In this position, Schetter will be working with a team of experienced scientists to further the company’s technological and scientific leadership in process development, as well as continuing to develop strategic innovation and partnerships.

Dr. Christian Schetter added: “I am extremely pleased to broaden this scientific focus and innovation in a targeted way to remain the ‘partner-of-choice’ for established as well as novel biopharmaceutical development and production.”

Related Content

No items found

Latest content